Metacrine Company

Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseases
Technology: Immunotherapy
Industry: Biotechnology, Health Care, Medical, Pharmaceutical
Headquarters: San Diego, California, United States
Founded Date: 2015
Employees Number: 11-50
Funding Status: IPO
Investors Number: 14
Total Funding: 173000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2019
Last Funding Type: Debt Financing

Visit Website
info@metacrine.com
Register and Claim Ownership